Skip to content
10-Q

Quarterly Report

SKINOVATION PHARMACEUTICAL INCORPORATED

0001554795-23-000243

← back to feed
Filed
Aug 3, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 3, 2023 708K sh
Cash And Equivalents Q2 2023 · Jun 30, 2023 $3.53K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $163
Current Liabilities Q2 2023 · Jun 30, 2023 $433.84K
Current Liabilities Q2 2023 · Dec 31, 2022 $411.5K
Total Liabilities Q2 2023 · Jun 30, 2023 $433.84K
Total Liabilities Q2 2023 · Dec 31, 2022 $411.5K
Current Assets Q2 2023 · Jun 30, 2023 $3.53K
Current Assets Q2 2023 · Dec 31, 2022 $163
Total Assets Q2 2023 · Jun 30, 2023 $3.53K
Total Assets Q2 2023 · Dec 31, 2022 $163
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$5.14K
Stockholders Equity Q2 2023 · Jun 30, 2022 −$395.82K
Stockholders Equity Q2 2023 · Mar 31, 2022 −$388.04K
Stockholders Equity Q2 2023 · Dec 31, 2021 −$377.59K
Sga Expense Q2 2023 · Jun 30, 2022 $2.88K
Sga Expense Q2 2023 · Jun 30, 2022 $8.49K
Net Income Q2 2023 · Jun 30, 2022 −$7.78K
Net Income Q2 2023 · Jun 30, 2022 −$18.23K
Net Income Q2 2023 · Mar 31, 2022 −$10.45K
Operating Income Q2 2023 · Jun 30, 2022 −$2.88K
Operating Income Q2 2023 · Jun 30, 2022 −$8.49K